dihexa tesofensine bpc157 Dihexa & Tesofensine Peptide Therapy Dallas | BPC-157,

RFK Jr is trying to get 14 peptides, without data on safety or efficacy, licensed and approved by FDA

* Correspondence: Katharina C

Curiosity about scientific innovation is valuable, but it should be paired with: Evidence-based evaluation Awareness of regulatory context Consultation with qualified professionals Caution regarding unverified claims Peptide science is advancing rapidly, and future therapeutic applications may become clearer as larger clinical trials conclude

M., & Hajiannia, A

it is a relative potency ratio , not a measurement of benefit and not anything measured in a human

A standard BPC-157 protocol typically runs daily injections over several weeks, but total milligrams vary by clinical goal